
You are here
Consultations
We conduct public consultations as part of our broader stakeholder engagement work, including on changes to regulatory requirements or practices, reviews of business processes, standards or guidelines, and TGA fees and charges.
Filters
Status
Categories
- Advertising (8) Apply Advertising filter
- Australian Register of Therapeutic Goods (ARTG) (1) Apply Australian Register of Therapeutic Goods (ARTG) filter
- Biologicals (9) Apply Biologicals filter
- Blood and blood components (4) Apply Blood and blood components filter
- Complementary medicines (22) Apply Complementary medicines filter
- Cosmetics (2) Apply Cosmetics filter
- Disinfectants/Sterilants (4) Apply Disinfectants/Sterilants filter
- Import/Export (1) Apply Import/Export filter
- Labelling/Packaging (23) Apply Labelling/Packaging filter
- Legislation (20) Apply Legislation filter
- Listed medicines (2) Apply Listed medicines filter
- Manufacturing (11) Apply Manufacturing filter
- Medical devices safety (1) Apply Medical devices safety filter
- Medical devices/IVDs (48) Apply Medical devices/IVDs filter
- Remove Medicinal cannabis filter Medicinal cannabis (1)
- Medicines (1) Apply Medicines filter
- OTC medicines (31) Apply OTC medicines filter
- Remove Prescription medicines filter Prescription medicines (25)
- Safety of medicines & medical devices (2) Apply Safety of medicines & medical devices filter
- Scheduling (37) Apply Scheduling filter
- Therapeutic Goods Administration (TGA) (6) Apply Therapeutic Goods Administration (TGA) filter
- Therapeutic goods regulation (6) Apply Therapeutic goods regulation filter
Consultations on adoption of European Union guidelines in Australia
Closed on 7 February 2020
Whether the TGA should publish that a prescription medicine is under evaluation
Closed on 29 March 2019
Reforms to the generic medicine market authorisation process
Closed on 21 March 2019
Transition to eCTD only for prescription medicines
Closed on 4 December 2018
Boxed Warning guidance
Closed on 31 August 2018
Management and communication of medicines shortages
Closed on 30 April 2018
Remaking of TGO No. 77 – Microbiological Standards for Medicines
Closed on 6 March 2018
Prescription strong (Schedule 8) opioid use and misuse in Australia – options for a regulatory response
Closed on 2 March 2018
Provisional Approval pathway for prescription medicines
Closed on 1 May 2017